Take off with Inovio Pharmaceuticals Inc (INO): Get ready for trading

With 0.68 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.75 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.625 whereas the lowest price it dropped to was $1.5597. The 52-week range on INO shows […]

A significant driver of top-line growth: Inovio Pharmaceuticals Inc (INO)

With 0.61 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.85 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.58 whereas the lowest price it dropped to was $1.5. The 52-week range on INO shows […]

Nothing is Better Than Inovio Pharmaceuticals Inc (INO) stock at the moment

With 2.02 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.84 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.98 whereas the lowest price it dropped to was $1.875. The 52-week range on INO shows […]

Does Inovio Pharmaceuticals Inc (INO) offer a good opportunity for investors?

With 0.6 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.87 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $2.13 whereas the lowest price it dropped to was $1.99. The 52-week range on INO shows […]

This trade activity should not be overlooked: Inovio Pharmaceuticals Inc (INO)

With 0.54 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.1 million shares. The 52-week range on INO shows that it touched its highest point at $14.75 and its lowest point at $1.74 during that stretch. It currently has a 1-year price target of $9.50. Beta for […]